DiaSorin and Tecan partner to develop new platform for molecular diagnostics applications

DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan’s Fluent® Laboratory Automation Solution as its nucleic acid extraction platform. The new platform will be used in combination with the DiaSorin Liaison® MDX PCR system to provide the customer with a complete sample to result system for molecular diagnostics.

The Fluent platform, to be supplied through Tecan Partnering, will be optimized for use with DiaSorin extraction chemistry and automated PCR set up of the Liaison MDX 96-well disc. Fluent breaks new ground, delivering more capacity and increased speed. The platform provides exceptional precision, throughput and walkaway time.

Dr David Martyr, CEO of Tecan, commented:

We are delighted that DiaSorin has chosen the Fluent Laboratory Automation Solution as the basis for this new platform. The precision, speed and low volume liquid handling accuracy offered by the Fluent are ideal for molecular diagnostics applications.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tecan. (2019, June 19). DiaSorin and Tecan partner to develop new platform for molecular diagnostics applications. News-Medical. Retrieved on September 16, 2019 from https://www.news-medical.net/news/20170705/DiaSorin-and-Tecan-partner-to-develop-new-platform-for-molecular-diagnostics-applications.aspx.

  • MLA

    Tecan. "DiaSorin and Tecan partner to develop new platform for molecular diagnostics applications". News-Medical. 16 September 2019. <https://www.news-medical.net/news/20170705/DiaSorin-and-Tecan-partner-to-develop-new-platform-for-molecular-diagnostics-applications.aspx>.

  • Chicago

    Tecan. "DiaSorin and Tecan partner to develop new platform for molecular diagnostics applications". News-Medical. https://www.news-medical.net/news/20170705/DiaSorin-and-Tecan-partner-to-develop-new-platform-for-molecular-diagnostics-applications.aspx. (accessed September 16, 2019).

  • Harvard

    Tecan. 2019. DiaSorin and Tecan partner to develop new platform for molecular diagnostics applications. News-Medical, viewed 16 September 2019, https://www.news-medical.net/news/20170705/DiaSorin-and-Tecan-partner-to-develop-new-platform-for-molecular-diagnostics-applications.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Tecan offers insights on automated liquid handling platform usage with connected laboratory automation